Treatment of Primary Ovarian Angiosarcoma with Ifosfamide and Doxorubicin
Angiosarcoma originating in the female genital tract is exceedingly rare with only 15 cases of angiosarcoma of the ovary described to date. All have been highly aggressive tumors, and no response to treatment has ever been reported. A case of primary ovarian angiosarcoma is described in which a shor...
Gespeichert in:
| Veröffentlicht in: | Gynecologic oncology 1994-05, Vol.53 (2), p.265-268 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 268 |
|---|---|
| container_issue | 2 |
| container_start_page | 265 |
| container_title | Gynecologic oncology |
| container_volume | 53 |
| creator | Cunningham, Mary Jadhon Brooks, John S.J. Noumoff, Joel S. |
| description | Angiosarcoma originating in the female genital tract is exceedingly rare with only 15 cases of angiosarcoma of the ovary described to date. All have been highly aggressive tumors, and no response to treatment has ever been reported. A case of primary ovarian angiosarcoma is described in which a short remission was achieved with intensive chemotherapy using ifosfamide and doxorubicin. |
| doi_str_mv | 10.1006/gyno.1994.1128 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76486501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090825884711280</els_id><sourcerecordid>76486501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-d9fe70e160f9d226789fb2fed8db2333ae6cd70c5f0fc48538c9b689b08415573</originalsourceid><addsrcrecordid>eNp1kD1PwzAQhi0EKqWwsiFlQGwp56RJ7LEqX5UqlaHMlmOfi1FjFzst9N-TqlU3phve517dPYTcUhhSgPJxuXN-SDkfDSnN2BnpU-BFWrKCn5M-AIeUZQW7JFcxfgFADjTrkR6jjAHP-mS6CCjbBl2beJO8B9vIsEvmWxmsdMnYLa2PMijfyOTHtp_J1PhoZGM1JtLp5Mn_-rCprbLumlwYuYp4c5wD8vHyvJi8pbP563QynqUq51Wbam6wAqQlGK6zrKwYN3VmUDNdZ3meSyyVrkAVBowasSJnitcl4zWwES2KKh-Qh0PvOvjvDcZWNDYqXK2kQ7-JoipHrCyAduDwAKrgYwxoxPrwnqAg9u7E3p3YuxN7d93C3bF5UzeoT_hRVpffH3MZlVyZIJ2y8YR15zFa8Q5jBww7C1uLQURl0SnUNqBqhfb2vwv-AKXuisQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76486501</pqid></control><display><type>article</type><title>Treatment of Primary Ovarian Angiosarcoma with Ifosfamide and Doxorubicin</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Cunningham, Mary Jadhon ; Brooks, John S.J. ; Noumoff, Joel S.</creator><creatorcontrib>Cunningham, Mary Jadhon ; Brooks, John S.J. ; Noumoff, Joel S.</creatorcontrib><description>Angiosarcoma originating in the female genital tract is exceedingly rare with only 15 cases of angiosarcoma of the ovary described to date. All have been highly aggressive tumors, and no response to treatment has ever been reported. A case of primary ovarian angiosarcoma is described in which a short remission was achieved with intensive chemotherapy using ifosfamide and doxorubicin.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1006/gyno.1994.1128</identifier><identifier>PMID: 8188092</identifier><identifier>CODEN: GYNOA3</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Adult ; Antineoplastic agents ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Biological and medical sciences ; Chemotherapy ; Doxorubicin - administration & dosage ; Female ; Hemangiosarcoma - drug therapy ; Hemangiosarcoma - pathology ; Humans ; Ifosfamide - administration & dosage ; Medical sciences ; Ovarian Neoplasms - drug therapy ; Ovarian Neoplasms - pathology ; Pharmacology. Drug treatments</subject><ispartof>Gynecologic oncology, 1994-05, Vol.53 (2), p.265-268</ispartof><rights>1994 Academic Press</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-d9fe70e160f9d226789fb2fed8db2333ae6cd70c5f0fc48538c9b689b08415573</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/gyno.1994.1128$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4158179$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8188092$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cunningham, Mary Jadhon</creatorcontrib><creatorcontrib>Brooks, John S.J.</creatorcontrib><creatorcontrib>Noumoff, Joel S.</creatorcontrib><title>Treatment of Primary Ovarian Angiosarcoma with Ifosfamide and Doxorubicin</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>Angiosarcoma originating in the female genital tract is exceedingly rare with only 15 cases of angiosarcoma of the ovary described to date. All have been highly aggressive tumors, and no response to treatment has ever been reported. A case of primary ovarian angiosarcoma is described in which a short remission was achieved with intensive chemotherapy using ifosfamide and doxorubicin.</description><subject>Adult</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy</subject><subject>Doxorubicin - administration & dosage</subject><subject>Female</subject><subject>Hemangiosarcoma - drug therapy</subject><subject>Hemangiosarcoma - pathology</subject><subject>Humans</subject><subject>Ifosfamide - administration & dosage</subject><subject>Medical sciences</subject><subject>Ovarian Neoplasms - drug therapy</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Pharmacology. Drug treatments</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kD1PwzAQhi0EKqWwsiFlQGwp56RJ7LEqX5UqlaHMlmOfi1FjFzst9N-TqlU3phve517dPYTcUhhSgPJxuXN-SDkfDSnN2BnpU-BFWrKCn5M-AIeUZQW7JFcxfgFADjTrkR6jjAHP-mS6CCjbBl2beJO8B9vIsEvmWxmsdMnYLa2PMijfyOTHtp_J1PhoZGM1JtLp5Mn_-rCprbLumlwYuYp4c5wD8vHyvJi8pbP563QynqUq51Wbam6wAqQlGK6zrKwYN3VmUDNdZ3meSyyVrkAVBowasSJnitcl4zWwES2KKh-Qh0PvOvjvDcZWNDYqXK2kQ7-JoipHrCyAduDwAKrgYwxoxPrwnqAg9u7E3p3YuxN7d93C3bF5UzeoT_hRVpffH3MZlVyZIJ2y8YR15zFa8Q5jBww7C1uLQURl0SnUNqBqhfb2vwv-AKXuisQ</recordid><startdate>19940501</startdate><enddate>19940501</enddate><creator>Cunningham, Mary Jadhon</creator><creator>Brooks, John S.J.</creator><creator>Noumoff, Joel S.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19940501</creationdate><title>Treatment of Primary Ovarian Angiosarcoma with Ifosfamide and Doxorubicin</title><author>Cunningham, Mary Jadhon ; Brooks, John S.J. ; Noumoff, Joel S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-d9fe70e160f9d226789fb2fed8db2333ae6cd70c5f0fc48538c9b689b08415573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adult</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy</topic><topic>Doxorubicin - administration & dosage</topic><topic>Female</topic><topic>Hemangiosarcoma - drug therapy</topic><topic>Hemangiosarcoma - pathology</topic><topic>Humans</topic><topic>Ifosfamide - administration & dosage</topic><topic>Medical sciences</topic><topic>Ovarian Neoplasms - drug therapy</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cunningham, Mary Jadhon</creatorcontrib><creatorcontrib>Brooks, John S.J.</creatorcontrib><creatorcontrib>Noumoff, Joel S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cunningham, Mary Jadhon</au><au>Brooks, John S.J.</au><au>Noumoff, Joel S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Primary Ovarian Angiosarcoma with Ifosfamide and Doxorubicin</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>1994-05-01</date><risdate>1994</risdate><volume>53</volume><issue>2</issue><spage>265</spage><epage>268</epage><pages>265-268</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><coden>GYNOA3</coden><abstract>Angiosarcoma originating in the female genital tract is exceedingly rare with only 15 cases of angiosarcoma of the ovary described to date. All have been highly aggressive tumors, and no response to treatment has ever been reported. A case of primary ovarian angiosarcoma is described in which a short remission was achieved with intensive chemotherapy using ifosfamide and doxorubicin.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>8188092</pmid><doi>10.1006/gyno.1994.1128</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0090-8258 |
| ispartof | Gynecologic oncology, 1994-05, Vol.53 (2), p.265-268 |
| issn | 0090-8258 1095-6859 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_76486501 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Adult Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Chemotherapy Doxorubicin - administration & dosage Female Hemangiosarcoma - drug therapy Hemangiosarcoma - pathology Humans Ifosfamide - administration & dosage Medical sciences Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology Pharmacology. Drug treatments |
| title | Treatment of Primary Ovarian Angiosarcoma with Ifosfamide and Doxorubicin |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T12%3A25%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Primary%20Ovarian%20Angiosarcoma%20with%20Ifosfamide%20and%20Doxorubicin&rft.jtitle=Gynecologic%20oncology&rft.au=Cunningham,%20Mary%20Jadhon&rft.date=1994-05-01&rft.volume=53&rft.issue=2&rft.spage=265&rft.epage=268&rft.pages=265-268&rft.issn=0090-8258&rft.eissn=1095-6859&rft.coden=GYNOA3&rft_id=info:doi/10.1006/gyno.1994.1128&rft_dat=%3Cproquest_cross%3E76486501%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76486501&rft_id=info:pmid/8188092&rft_els_id=S0090825884711280&rfr_iscdi=true |